We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

17 hedge funds and large institutions have $782K invested in Redhill Biopharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

87% more capital invested

Capital invested by funds: $419K → $782K (+$363K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

6% less funds holding

Funds holding: 18 → 17 (-1)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
2
Closed
3
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
-$11K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$756K
2
SM
Sabby Management
Florida
+$664K
3
GS
Gagnon Securities
New York
+$50.2K
4
Citadel Advisors
Citadel Advisors
Florida
+$41.9K
5
TSS
Two Sigma Securities
New York
+$12.8K

Top Sellers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
-$346K
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$1.26K
3
UBS Group
UBS Group
Switzerland
-$523
4
Morgan Stanley
Morgan Stanley
New York
-$209
5
JP Morgan Chase
JP Morgan Chase
New York
-$78
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$369K +$756K +28,916 New
SM
2
Sabby Management
Florida
$324K +$664K +25,400 New
Citadel Advisors
3
Citadel Advisors
Florida
$28.4K +$41.9K +1,602 +255%
GS
4
Gagnon Securities
New York
$24.5K +$50.2K +1,919 New
TSS
5
Two Sigma Securities
New York
$12.9K +$12.8K +489 +93%
VF
6
Virtu Financial
New York
$10K +$9.57K +366 +85%
MOS
7
MGO One Seven
Ohio
$8.03K +$5.23K +200 +47%
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.25K – – –
RhumbLine Advisers
9
RhumbLine Advisers
Massachusetts
$1.54K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$1K +$2.2K +84 +1,400%
Group One Trading
11
Group One Trading
Illinois
$314 – – –
Morgan Stanley
12
Morgan Stanley
New York
$205 -$209 -8 -33%
SPIA
13
Steward Partners Investment Advisory
New York
$64 – – –
Osaic Holdings
14
Osaic Holdings
Arizona
$58 – – –
UBS Group
15
UBS Group
Switzerland
$36 -$523 -20 -87%
Bank of America
16
Bank of America
North Carolina
$16 – – –
Wells Fargo
17
Wells Fargo
California
$12 – – –
JP Morgan Chase
18
JP Morgan Chase
New York
$4 -$78 -3 Closed
IA
19
IFP Advisors
Florida
$4 – – –
CAC
20
Cowen and Company
New York
– -$346K -11,520 Closed
National Bank of Canada
21
National Bank of Canada
Quebec, Canada
– -$1.26K -43 Closed
NC
22
NewSquare Capital
Pennsylvania
– -$2 – –
S
23
SignatureFD
Georgia
– -$2 – –

RDHL Hedge Fund Activity: Q3 2023 in Review

17 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2023, worth a combined $782K — up 87% from $419K a quarter earlier.

Fund positioning in RDHL was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $756K. The largest seller was Cowen and Company, exiting entirely with an estimated $346K sold.

  • 17 institutional investors held Redhill Biopharma (RDHL) as of Q3 2023, down from 18 in Q2 2023.
  • Funds reported $782K of Redhill Biopharma stock for Q3 2023, up 87% quarter-over-quarter.
  • 3 funds opened new Redhill Biopharma positions in Q3 2023 and 3 closed out, a net change of 0 holders.
  • The largest Redhill Biopharma buyer in Q3 2023 was Armistice Capital, an estimated $756K added.
  • The largest Redhill Biopharma seller in Q3 2023 was Cowen and Company, an estimated $346K sold.

Based on aggregated 13F filings for Q3 2023.